These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 21166896)
21. Cell-based and multi-omics profiling reveals dynamic metabolic repurposing of mitochondria to drive developmental progression of Trypanosoma brucei. Doleželová E; Kunzová M; Dejung M; Levin M; Panicucci B; Regnault C; Janzen CJ; Barrett MP; Butter F; Zíková A PLoS Biol; 2020 Jun; 18(6):e3000741. PubMed ID: 32520929 [TBL] [Abstract][Full Text] [Related]
22. Targeting calcium homeostasis as the therapy of Chagas' disease and leishmaniasis - a review. Benaim B; Garcia CR Trop Biomed; 2011 Dec; 28(3):471-81. PubMed ID: 22433874 [TBL] [Abstract][Full Text] [Related]
23. Antiprotozoal and cytotoxic screening of 45 plant extracts from Democratic Republic of Congo. Mesia GK; Tona GL; Nanga TH; Cimanga RK; Apers S; Cos P; Maes L; Pieters L; Vlietinck AJ J Ethnopharmacol; 2008 Feb; 115(3):409-15. PubMed ID: 18068320 [TBL] [Abstract][Full Text] [Related]
24. Trypanocidal activity of salinomycin is due to sodium influx followed by cell swelling. Steverding D; Sexton DW Parasit Vectors; 2013 Mar; 6():78. PubMed ID: 23517602 [TBL] [Abstract][Full Text] [Related]
26. Antiproliferative effect of dihydroxyacetone on Trypanosoma brucei bloodstream forms: cell cycle progression, subcellular alterations, and cell death. Uzcátegui NL; Carmona-Gutiérrez D; Denninger V; Schoenfeld C; Lang F; Figarella K; Duszenko M Antimicrob Agents Chemother; 2007 Nov; 51(11):3960-8. PubMed ID: 17682096 [TBL] [Abstract][Full Text] [Related]
27. Trypanosoma brucei RNA triphosphatase. Antiprotozoal drug target and guide to eukaryotic phylogeny. Ho CK; Shuman S J Biol Chem; 2001 Dec; 276(49):46182-6. PubMed ID: 11553645 [TBL] [Abstract][Full Text] [Related]
28. Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs. Munday JC; Eze AA; Baker N; Glover L; Clucas C; Aguinaga Andrés D; Natto MJ; Teka IA; McDonald J; Lee RS; Graf FE; Ludin P; Burchmore RJ; Turner CM; Tait A; MacLeod A; Mäser P; Barrett MP; Horn D; De Koning HP J Antimicrob Chemother; 2014 Mar; 69(3):651-63. PubMed ID: 24235095 [TBL] [Abstract][Full Text] [Related]
29. Biological characterization of chemically diverse compounds targeting the Plasmodium falciparum coenzyme A synthesis pathway. Fletcher S; Lucantoni L; Sykes ML; Jones AJ; Holleran JP; Saliba KJ; Avery VM Parasit Vectors; 2016 Nov; 9(1):589. PubMed ID: 27855724 [TBL] [Abstract][Full Text] [Related]
30. Optimal kinetic exposures for classic and candidate antitrypanosomals. Meyer KJ; Meyers DJ; Shapiro TA J Antimicrob Chemother; 2019 Aug; 74(8):2303-2310. PubMed ID: 31093674 [TBL] [Abstract][Full Text] [Related]
31. Metabolic control analysis of glycolysis in trypanosomes as an approach to improve selectivity and effectiveness of drugs. Bakker BM; Westerhoff HV; Opperdoes FR; Michels PA Mol Biochem Parasitol; 2000 Feb; 106(1):1-10. PubMed ID: 10743606 [TBL] [Abstract][Full Text] [Related]
32. Vinyl sulfone-based inhibitors of trypanosomal cysteine protease rhodesain with improved antitrypanosomal activities. Zhang H; Collins J; Nyamwihura R; Crown O; Ajayi O; Ogungbe IV Bioorg Med Chem Lett; 2020 Jul; 30(14):127217. PubMed ID: 32527539 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of anti-sleeping-sickness drugs and topoisomerase inhibitors in combination on Trypanosoma brucei. Steverding D; Wang X J Antimicrob Chemother; 2009 Jun; 63(6):1293-5. PubMed ID: 19336455 [No Abstract] [Full Text] [Related]
34. Evaluation of the Trypanosoma brucei 6-oxopurine salvage pathway as a potential target for drug discovery. Doleželová E; Terán D; Gahura O; Kotrbová Z; Procházková M; Keough D; Špaček P; Hocková D; Guddat L; Zíková A PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006301. PubMed ID: 29481567 [TBL] [Abstract][Full Text] [Related]
36. Tsetse fly tolerance to T. brucei infection: transcriptome analysis of trypanosome-associated changes in the tsetse fly salivary gland. Matetovici I; Caljon G; Van Den Abbeele J BMC Genomics; 2016 Nov; 17(1):971. PubMed ID: 27884110 [TBL] [Abstract][Full Text] [Related]
37. Post-translational import of protein into the endoplasmic reticulum of a trypanosome: an in vitro system for discovery of anti-trypanosomal chemical entities. Patham B; Duffy J; Lane A; Davis RC; Wipf P; Fewell SW; Brodsky JL; Mensa-Wilmot K Biochem J; 2009 Apr; 419(2):507-17. PubMed ID: 19196237 [TBL] [Abstract][Full Text] [Related]
38. Spiro-containing derivatives show antiparasitic activity against Trypanosoma brucei through inhibition of the trypanothione reductase enzyme. Turcano L; Battista T; De Haro ET; Missineo A; Alli C; Paonessa G; Colotti G; Harper S; Fiorillo A; Ilari A; Bresciani A PLoS Negl Trop Dis; 2020 May; 14(5):e0008339. PubMed ID: 32437349 [TBL] [Abstract][Full Text] [Related]
39. In vitro cytocidal effects on Trypanosoma brucei and inhibition of Leishmania major GP63 by peptidomimetic metalloprotease inhibitors. Bangs JD; Ransom DA; Nimick M; Christie G; Hooper NM Mol Biochem Parasitol; 2001 Apr; 114(1):111-7. PubMed ID: 11356520 [TBL] [Abstract][Full Text] [Related]
40. Trypanosoma brucei: chemical evidence that cathepsin L is essential for survival and a relevant drug target. Steverding D; Sexton DW; Wang X; Gehrke SS; Wagner GK; Caffrey CR Int J Parasitol; 2012 May; 42(5):481-8. PubMed ID: 22549023 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]